These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9607556)

  • 21. Genetic variability of the human SRD5A2 gene: implications for prostate cancer risk.
    Reichardt JK; Makridakis N; Henderson BE; Yu MC; Pike MC; Ross RK
    Cancer Res; 1995 Sep; 55(18):3973-5. PubMed ID: 7664265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A polymorphism of the 5 alpha-reductase gene and its association with prostate cancer: a case-control analysis.
    Kantoff PW; Febbo PG; Giovannucci E; Krithivas K; Dahl DM; Chang G; Hennekens CH; Brown M; Stampfer MJ
    Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):189-92. PubMed ID: 9138662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans.
    Haiman CA; Chen GK; Blot WJ; Strom SS; Berndt SI; Kittles RA; Rybicki BA; Isaacs WB; Ingles SA; Stanford JL; Diver WR; Witte JS; Chanock SJ; Kolb S; Signorello LB; Yamamura Y; Neslund-Dudas C; Thun MJ; Murphy A; Casey G; Sheng X; Wan P; Pooler LC; Monroe KR; Waters KM; Le Marchand L; Kolonel LN; Stram DO; Henderson BE
    PLoS Genet; 2011 May; 7(5):e1001387. PubMed ID: 21637779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals.
    Platz EA; Rimm EB; Willett WC; Kantoff PW; Giovannucci E
    J Natl Cancer Inst; 2000 Dec; 92(24):2009-17. PubMed ID: 11121463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada.
    Whittemore AS; Wu AH; Kolonel LN; John EM; Gallagher RP; Howe GR; West DW; Teh CZ; Stamey T
    Am J Epidemiol; 1995 Apr; 141(8):732-40. PubMed ID: 7535977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perspective: prostate cancer susceptibility genes.
    Simard J; Dumont M; Soucy P; Labrie F
    Endocrinology; 2002 Jun; 143(6):2029-40. PubMed ID: 12021166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate Cancer Genomics: Recent Advances and the Prevailing Underrepresentation from Racial and Ethnic Minorities.
    Tan SH; Petrovics G; Srivastava S
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29690565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer.
    Xu J; Zheng SL; Carpten JD; Nupponen NN; Robbins CM; Mestre J; Moses TY; Faith DA; Kelly BD; Isaacs SD; Wiley KE; Ewing CM; Bujnovszky P; Chang B; Bailey-Wilson J; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB
    Am J Hum Genet; 2001 Apr; 68(4):901-11. PubMed ID: 11254448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. African-American heredity prostate cancer study: a model for genetic research.
    Powell IJ; Carpten J; Dunston G; Kittles R; Bennett J; Hoke G; Pettaway C; Weinrich S; Vijayakumar S; Ahaghotu CA; Boykin W; Mason T; Royal C; Baffoe-Bonnie A; Bailey-Wilson J; Berg K; Trent J; Collins F
    J Natl Med Assoc; 2001 Dec; 93(12 Suppl):25S-28S. PubMed ID: 11798061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2).
    Lunn RM; Bell DA; Mohler JL; Taylor JA
    Carcinogenesis; 1999 Sep; 20(9):1727-31. PubMed ID: 10469617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Global prostate cancer incidence and the migration, settlement, and admixture history of the Northern Europeans.
    Gunderson K; Wang CY; Wang R
    Cancer Epidemiol; 2011 Aug; 35(4):320-7. PubMed ID: 21167803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Replication and heritability of prostate cancer risk variants: impact of population-specific factors.
    Virlogeux V; Graff RE; Hoffmann TJ; Witte JS
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):938-43. PubMed ID: 25809866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ethnic differences in the frequency of prostate cancer susceptibility alleles at SRD5A2 and CYP3A4.
    Zeigler-Johnson CM; Walker AH; Mancke B; Spangler E; Jalloh M; McBride S; Deitz A; Malkowicz SB; Ofori-Adjei D; Gueye SM; Rebbeck TR
    Hum Hered; 2002; 54(1):13-21. PubMed ID: 12446983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 8q24 risk alleles in West African and Caribbean men.
    Murphy AB; Ukoli F; Freeman V; Bennett F; Aiken W; Tulloch T; Coard K; Angwafo F; Kittles RA
    Prostate; 2012 Sep; 72(12):1366-73. PubMed ID: 22234922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of an allelic variant in the nifedipine-specific element of CYP3A4: ethnic distribution and implications for prostate cancer risk. Mutations in brief no. 191. Online.
    Walker AH; Jaffe JM; Gunasegaram S; Cummings SA; Huang CS; Chern HD; Olopade OI; Weber BL; Rebbeck TR
    Hum Mutat; 1998; 12(4):289. PubMed ID: 10660343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hereditary prostate cancer in African American families: linkage analysis using markers that map to five candidate susceptibility loci.
    Brown WM; Lange EM; Chen H; Zheng SL; Chang B; Wiley KE; Isaacs SD; Walsh PC; Isaacs WB; Xu J; Cooney KA
    Br J Cancer; 2004 Jan; 90(2):510-4. PubMed ID: 14735201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Links between genetic and environmental factors and prostate cancer risk.
    Ekman P; Grönberg H; Matsuyama H; Kivineva M; Bergerheim US; Li C
    Prostate; 1999 Jun; 39(4):262-8. PubMed ID: 10344215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Re: Prostate cancer and the androgen receptor.
    Coetzee GA; Ross RK
    J Natl Cancer Inst; 1994 Jun; 86(11):872-3. PubMed ID: 8182772
    [No Abstract]   [Full Text] [Related]  

  • 40. Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk.
    Xu J; Zheng SL; Komiya A; Mychaleckyj JC; Isaacs SD; Hu JJ; Sterling D; Lange EM; Hawkins GA; Turner A; Ewing CM; Faith DA; Johnson JR; Suzuki H; Bujnovszky P; Wiley KE; DeMarzo AM; Bova GS; Chang B; Hall MC; McCullough DL; Partin AW; Kassabian VS; Carpten JD; Bailey-Wilson JE; Trent JM; Ohar J; Bleecker ER; Walsh PC; Isaacs WB; Meyers DA
    Nat Genet; 2002 Oct; 32(2):321-5. PubMed ID: 12244320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.